2nd International Conference on Fostering Interdisciplinary Research In Health Sciences (ICFIRHS) 2019 (01-May-2019)        |

Journal :   Research Journal of Pharmacy and Technology

Volume No. :   2

Issue No. :  1

Year :  2009

Pages :   8-11

ISSN Print :  0974-3618

ISSN Online :  0974-360X


Allready Registrered
Click to Login

The Biopharmaceutics Classification System: A Review

Address:   SV Deshmane*, PP Chinchole, RM Gaurkhede, MA Channawar and AV Chandewar.
P. Wadhwani College of Pharmacy, Dhamangaon road, Girija Nagar, Yavatmal – 445001 (M.S.)
*Corresponding Author

The reports dealing with solubility, dissolution issues related to BCS, prompted us to re-examine theoretically the role of the dimensionless solubility/dose ratio in the dissolution and GI absorption kinetics of drugs. In parallel, this study pays attention not only to the theoretical basis for the biopharmaceutics classification of new molecular entities (NMEs), but also for marketed drugs. Early high throughput screening information regarding solubility and permeability should be invaluable to discovery chemists. While savings resulting from application of the BCS to obtain waivers of in vivo bioequivalence studies are notable, they may not represent the most significant benefit from application of the BCS. The BCS was primarily developed for a better understanding of the relationship of drug release (in vivo) from the product and the absorption process. In this respect, the question of the rate-limiting step is of primary relevance. Further, it has been reported that 39% of compounds in development fail because of poor biopharmaceutical properties
Biopharmaceutics Classification system, Solubility, Permeability and Bioequivalence.
SV Deshmane, PP Chinchole, RM Gaurkhede, MA Channawar, AV Chandewar. The Biopharmaceutics Classification System: A Review. Research J. Pharm. and Tech. 2(1): Jan.-Mar. 2009; Page 8-11
[View HTML]      [View PDF]

Visitor's No. :   645330